continentalic acid: from Acanthopanax species; structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Acanthopanax | genus | [no description available] | Araliaceae | The ginseng plant family of the order Apiales, subclass Rosidae, class Magnoliopsida. Leaves are generally alternate, large, and compound. Flowers are five-parted and arranged in compound flat-topped umbels. The fruit is a berry or (rarely) a drupe (a one-seeded fruit). It is well known for plant preparations used as adaptogens (immune support and anti-fatigue).[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 10116 |
SCHEMBL ID | 10819486 |
MeSH ID | M0498550 |
Synonym |
---|
.delta.8(14)-pimaric acid |
podocarp-8(14)-en-15-oic acid, 13.alpha.-methyl-13-vinyl- |
nsc-231381 |
nsc231381 |
pimara-8(14),15-dien-18-oic acid |
nsc 2956 |
FT-0673901 |
SCHEMBL10819486 |
1-phenanthrenecarboxylic acid, 7-ethenyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-1,4a,7-trimethyl-, [1r-(1.alpha.,4a.beta.,4b.alpha.,7.beta.,10a.alpha.)]- |
MHVJRKBZMUDEEV-UHFFFAOYSA-N |
8(14),15-pimaradien-18-oic acid |
19889-23-7 |
continentalic acid |
FT-0775512 |
DTXSID20861776 |
8(4), 15-pimaradien-18-oic acid |
Continentalic acid is a natural drug product found in roots of Aralia continentalis (family Araliaceae) Used in traditional medicine for treatment of rheumatic arthritis, lumbag, lameness, inflammation, gastritis, nephritis and diabetes mellitus.
Excerpt | Reference | Relevance |
---|---|---|
"Continentalic acid is a natural drug product found in roots of Aralia continentalis (family Araliaceae), which used in traditional medicine for treatment of rheumatic arthritis, lumbag, lameness, inflammation, gastritis, nephritis and diabetes mellitus." | ( Pharmacological evaluation of continentalic acid for antidiabetic potential. Khan, AU; Khan, S; Liaquat, I, 2021) | 1.63 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 5 (45.45) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.52) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |